Skip to main content

Advertisement

SpringerLink
Log in

Clinicopathological characteristics, molecular subgrouping, and expression of miR-379/miR-656 cluster (C14MC) in adult medulloblastomas

  • Laboratory Investigation
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Medulloblastoma (MB) is a childhood tumor comprising four molecular subgroups: WNT, SHH, group 3 and group 4, with diagnostic and prognostic connotations. Very few studies are available on molecular subgrouping of adult MBs due to their rarity. Recently, loss of chromosome14q has been reported in SHH MBs, with downregulation of miR-379/miR-656 cluster (C14MC) in pediatric SHH MBs. Hence, the present study on adult MBs was undertaken to enumerate clinicopathological characteristics and molecular subgroups, and to analyze expression of C14MC and its transcriptional regulators, MEF2, JUN and ESRRG. Immunohistochemistry for β-catenin, GAB1 and YAP1 was performed to identify molecular subgroups. MYC amplification was evaluated by FISH. Expression profiling of 47 miRNAs from C14MC was performed using customized Taqman low-density array. Expression of transcriptional regulators was examined using RT-PCR. Seventy-one adult MBs were analyzed. They had male predominance and majority were located laterally (52 %). A significant proportion of cases were of Desmoplastic/nodular histology (32 %); MBEN was not seen. WNT tumors constituted 4.2 %, SHH 62 %, and non-WNT/non-SHH 33.8 %. MYC amplification was identified in 11.1 % cases. Patient outcome was worse in adults. Significant downregulation of C14MC was observed in all MB subgroups, and MEF-2 expression was downregulated. Adult MBs are distinct from childhood MBs in terms of location, histopathological subtypes, molecular subgroups, as well as prognosis. Silencing of C14MC in all MB subgroups suggests its role as a tumor suppressor locus in tumorigenesis. Deregulation of C14MC can possibly be attributed to repression of MEF2.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Giangaspero F, Eberhart CG, Haapasalo H, Pietsch T, Wiestler OD, Ellison DW (2007) Medulloblastoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) WHO classification of tumors of the central nervous system. IARC: Lyon, 132–140

    Google Scholar 

  2. Taylor MD, Northcott PA, Korshunov A et al (2012) Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol 123:465–472

    Article  CAS  PubMed  Google Scholar 

  3. Kaur K, Kakkar A, Kumar A et al (2016) Integrating molecular subclassification of medulloblastomas into routine clinical practice: a simplified approach. Brain Pathol 26:334–343

    Article  CAS  PubMed  Google Scholar 

  4. Ellison DW, Dalton J, Kocak M et al (2011) Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups. Acta Neuropathol 121:381–396

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Louis DN, Ohgaki H, Wiestler OD et al (2007) The 2007 WHO classification of tumors of the central nervous system. Acta Neuropathol 114:97–109

    Article  PubMed  PubMed Central  Google Scholar 

  6. Kool M, Korshunov A, Remke M et al (2012) Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, group 3, and group 4 medulloblastomas. Acta Neuropathol 123:473–484

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Sarkar C, Pramanik P, Karak AK et al (2002) Are childhood and adult medulloblastomas different? A comparative study of clinicopathological features, proliferation index and apoptotic index. J Neurooncol 59:49–61

    Article  PubMed  Google Scholar 

  8. Remke M, Hielscher T, Northcott PA et al (2011) Adult medulloblastoma comprises three major molecular variants. J Clin Oncol 29:2717–2723

    Article  PubMed  Google Scholar 

  9. Al-Halabi H, Nantel A, Klekner A et al (2011) Preponderance of sonic hedgehog pathway activation characterizes adult medulloblastoma. Acta Neuropathol 121:229–239

    Article  PubMed  Google Scholar 

  10. Northcott AP, Korshunov A, Witt H et al (2011) Medulloblastoma comprises four distinct molecular variants. J Clin Oncol 29:1408–1414

    Article  PubMed  Google Scholar 

  11. Shih DJH, Northcott PA, Remke M et al (2014) Cytogenetic prognostication within medulloblastoma subgroups. Clin Oncol 32:886–896

    Article  Google Scholar 

  12. da Rocha ST, Edwards CA, Ito M, Ogata T, Ferguson- Smith AC (2008) Genomic imprinting at the mammalian Dlk1-Dio3 domain. Trends Genet 24:306–316

    Article  PubMed  Google Scholar 

  13. Fiore R, Khudayberdiev S, Christensen M (2009) Mef2-mediated transcription of the miR379–410 cluster regulates activity-dependent dendritogenesis by fine-tuning Pumilio2 protein levels. EMBO J 28:697–710

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Lucon DR, Rocha CS, Craveiro RB et al (2013) Downregulation of 14q32 microRNAs in primary human desmoplastic medulloblastoma. Front Oncol 3:254

    Google Scholar 

  15. Laddha SV, Nayak S, Paul D et al (2013) Genome-wide analysis reveals downregulation of miR-379/miR-656 cluster in human cancers. Biol Direct 8:10

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Genovesi LA, Carter KW, Gottardo NG et al (2011) Integrated analysis of miRNA and mRNA expression in childhood medulloblastoma compared with neural stem cells. PLoS One 6:e23935

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2∆∆Ct method. Methods 25:402–408

    Article  CAS  PubMed  Google Scholar 

  18. Smoll NR, Drummond KJ (2012) The incidence of medulloblastomas and primitive neurectodermal tumours in adults and children. J Clin Neurosci 19:1541–1544

    Article  PubMed  Google Scholar 

  19. Gibson P, Tong Y, Robinson G et al (2010) Subtypes of medulloblastoma have distinct developmental origins. Nature 468:1095–1099

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Smoll NR (2012) Relative survival of childhood and adult medulloblastomas and primitive neuroectodermal tumors (PNETs). Cancer 118:1313–1322

    Article  PubMed  Google Scholar 

  21. Winter J (2015) MicroRNAs of the miR379–410 cluster: new players in embryonic neurogenesis and regulators of neuronal function. Neurogenesis 2:e1004970.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Altuvia Y, Landgraf P, Lithwick G et al (2005) Clustering and conservation patterns of human microRNAs. Nucleic Acids Res 33:2697–2706

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Kim VN, Nam JW (2006) Genomics of microRNA. Trends Genet 22:165–173

    Article  CAS  PubMed  Google Scholar 

  24. Gokhale A, Kunder R, Goel A et al (2010) Distinctive microRNA signature of medulloblastomas associated with the WNT signaling pathway. J Cancer Res Ther 6(521–52):9

    Google Scholar 

  25. Zehavi L, Avraham R, Barzilai A et al (2012) Silencing of a large microRNA cluster on human chromosome 14q32 in melanoma: biological effects of mir-376a and mir-376c on insulin growth factor 1 receptor. Mol Cancer 11:44

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Gattolliat CH, Thomas L, Ciafrè SA et al (2011) Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastoma. Br J Cancer 105:1352–1361

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Nadal E, Zhong J, Lin J, et al (2014) A MicroRNA cluster at 14q32 drives aggressive lung adenocarcinoma. ClinCancer Res 20:3107–3117.

    CAS  Google Scholar 

  28. Costa FF, Bischof JM, Vanin EF et al (2011) Identification of microRNAs as potential prognostic markers in ependymoma. PLoS One 6:e25114

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Northcott PA, Fernandez LA, Hagan JP et al (2009) The miR- 17/92 polycistron is upregulated in Sonic Hedgehog driven medulloblastomas and induced by Nmyc in Sonic Hedgehog-treated cerebellar neural precursors. Cancer Res 69:3249–3255

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Luo X, Liu J, Cheng SY (2011) The role of microRNAs during genesis of medulloblastoma induced by hedgehog pathway. Biomed Res 25:42–48

    Article  CAS  Google Scholar 

  31. Vogt PK (2002) Fortuitous convergences: the beginnings of JUN. Nat Rev Cancer 2:465–469

    Article  CAS  PubMed  Google Scholar 

  32. Nateri AS, Spencer-Dene B, Behrens A (2005) Interaction of phosphorylated c-Jun with TCF4 regulates intestinal cancer development. Nature 437:281–285

    Article  CAS  PubMed  Google Scholar 

  33. Gurzov EN, Bakiri L, Alfaro JM, Wagner EF, Izquierdo M (2008) Targeting Jun and JunB proteins as potential anticancer cell therapy. Oncogene 27:641–652

    Article  CAS  PubMed  Google Scholar 

  34. Robinson GW, Orr BA, Wu G et al (2015) Vismodegib exerts targeted efficacy against recurrent Sonic Hedgehog-subgroup medulloblastoma: results from phase II pediatric brain tumor consortium studies PBTC-025B and PBTC-032. J Clin Oncol 3:2646–2654

    Article  Google Scholar 

  35. Rudin CM, Hann CL, Laterra J et al (2009) Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. N Engl J Med 361:1173–1178

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, All India Institute of Medical Sciences, New Delhi, 110029, India

    Kavneet Kaur, Aanchal Kakkar, Anupam Kumar, Suvendu Purkait, Vaishali Suri, Mehar C. Sharma & Chitra Sarkar

  2. Department of Radiation Oncology, All India Institute of Medical Sciences, New Delhi, India

    Supriya Mallick & Pramod K. Julka

  3. Department of Neurosurgery, All India Institute of Medical Sciences, New Delhi, India

    Deepak Gupta & Ashish Suri

Authors
  1. Kavneet Kaur
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Aanchal Kakkar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anupam Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Suvendu Purkait
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Supriya Mallick
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Vaishali Suri
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mehar C. Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Pramod K. Julka
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Deepak Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Ashish Suri
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Chitra Sarkar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chitra Sarkar.

Additional information

Kavneet Kaur and Aanchal Kakkar are co-first authors and have contributed equally to the manuscript.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 49 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kaur, K., Kakkar, A., Kumar, A. et al. Clinicopathological characteristics, molecular subgrouping, and expression of miR-379/miR-656 cluster (C14MC) in adult medulloblastomas. J Neurooncol 130, 423–430 (2016). https://doi.org/10.1007/s11060-016-2250-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-016-2250-6

Keywords

Search

Navigation